Program Overview

Treatment Resistant Schizophrenia

Update your knowledge and clinical skills to provide higher quality patient care to people with treatment-resistant schizophrenia.

Course Overview

This self-guided online course brings together the latest research and developments in clinical practice to provide health professionals with a comprehensive understanding and up-to-date summary of the epidemiology, assessment, and treatment of treatment-resistant schizophrenia.

What You Will Learn

Gain contemporary skills and knowledge in the evaluation and management of treatment-resistant schizophrenia. Approximately 30% of people with schizophrenia have treatment-resistant schizophrenia, meaning they have not responded to at least two antipsychotic trials. Research into treatment-resistant schizophrenia is ongoing, with developments in assessment and treatment helping to improve the functional outcomes and quality of life of individuals and their carers.

Course Details

• Duration: Start anytime from January 2025
• Location: Online
• Fees: $55.00 AUD (inc GST)
• Start Date: 1 January 2025

What You Will Gain

• Deeper knowledge of treatment-resistant schizophrenia by exploring its epidemiology
• Understanding of the evaluation of treatment-resistant schizophrenia as well as medication and management
• Practical tools to apply to your practice, including guidelines for assessment
• Insight into the role of clozapine in treatment, including monitoring requirements, clozapine resistance, and augmentation

Course Structure

The course is designed to provide a comprehensive understanding of treatment-resistant schizophrenia, covering key topics such as:

• What is treatment-resistant schizophrenia
• Epidemiology of treatment-resistant schizophrenia
• Role of clozapine and monitoring requirements
• Clozapine resistance and augmentation

Target Audience

This course is designed for qualified psychiatrists and general practitioners working in mental health. Allied mental health professionals and psychologists working with people who have schizophrenia will also benefit from this course. There are no eligibility requirements.

Relevance to Your Job and Industry

This course has been developed in close consultation with industry to provide practical knowledge and skills that can be applied immediately to your practice, allowing you to provide higher quality patient care to those with this condition. The module is equivalent to one hour of continuing professional development, subject to peer group approval.

Course Developers

The course has been developed and designed by experts from the Department of Psychiatry, including the Head of the Melbourne Medical School and professor of medicine, and a senior lecturer at the Department of Psychiatry, in close consultation with industry.